Voluntary delisting from Euronext Amsterdam in Dec 2022
CLB - Core Laboratories N.V.
AMS
->
Energy
->
Oil & Gas Equipment & Services
Amstelveen,
Netherlands
Type: Equity
CLB price evolution
CLB
| (in millions $) | 29 Oct 2021 | 29 Jul 2021 | 30 Apr 2021 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $19.05 | $33.62 | $27.81 | $13.81 |
| Short term investments | ||||
| Net receivables | $107.77 | $110.17 | $99.94 | $92.87 |
| Inventory | $44.06 | $38.95 | $39.12 | $38.15 |
| Total current assets | $187.25 | $201.15 | $185.82 | $165.85 |
| Long term investments | ||||
| Property, plant & equipment | $112.74 | $112.4 | $113.49 | $115.29 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $399.03 | $397.28 | $398.63 | $402.73 |
| Total investments | ||||
| Total assets | $586.28 | $598.42 | $584.45 | $568.58 |
| Current liabilities | ||||
| Accounts payable | $35.02 | $30.38 | $25.5 | $23.03 |
| Deferred revenue | $6.87 | $6.41 | $5.86 | $5.46 |
| Short long term debt | ||||
| Total current liabilities | $92.95 | $90.85 | $85.53 | $89.75 |
| Long term debt | $188.46 | $208.31 | $208.17 | $259.43 |
| Total noncurrent liabilities | $332.31 | $353.23 | $352.87 | $403.26 |
| Total debt | ||||
| Total liabilities | $425.26 | $444.08 | $438.4 | $493.01 |
| Shareholders' equity | ||||
| Retained earnings | $66.12 | $65.71 | $58.12 | $50.46 |
| Other shareholder equity | -$5.32 | -$5.81 | -$3.62 | -$3.21 |
| Total shareholder equity | ||||
| (in millions $) | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 | 30 Jan 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $13.81 | $11.09 | $13.12 | $14.4 |
| Short term investments | ||||
| Net receivables | $92.87 | $138.11 | $143.15 | $140.6 |
| Inventory | $38.15 | $50.16 | $45.66 | $33.32 |
| Total current assets | $165.85 | $221.24 | $230.98 | $207.43 |
| Long term investments | ||||
| Property, plant & equipment | $115.29 | $123.51 | $122.92 | $123.1 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $402.73 | $553.44 | $417.85 | $377.38 |
| Total investments | ||||
| Total assets | $568.58 | $774.67 | $648.83 | $584.81 |
| Current liabilities | ||||
| Accounts payable | $23.03 | $35.61 | $41.16 | $41.7 |
| Deferred revenue | $5.46 | $13.38 | $17.32 | $12.63 |
| Short long term debt | ||||
| Total current liabilities | $89.75 | $111.59 | $102.55 | $100.58 |
| Long term debt | $259.43 | $305.28 | $289.77 | $226.99 |
| Total noncurrent liabilities | $403.26 | $480.94 | $385.38 | $335.5 |
| Total debt | ||||
| Total liabilities | $493.01 | $592.53 | $487.93 | $436.08 |
| Shareholders' equity | ||||
| Retained earnings | $50.46 | $160.54 | $156.13 | $173.85 |
| Other shareholder equity | -$3.21 | -$2.42 | -$0.82 | -$4.73 |
| Total shareholder equity | ||||
| (in millions $) | 29 Oct 2021 | 29 Jul 2021 | 30 Apr 2021 | 30 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $117.98 | $118.75 | $108.38 | $113.75 |
| Cost of revenue | ||||
| Gross Profit | $25.07 | $24.9 | $24.23 | $25.83 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $19.34 | $12.95 | $12.76 | $3.35 |
| Operating income | $6.64 | $12.8 | $11.62 | $23.4 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $2.96 | $2.05 | $2.05 | $6.54 |
| Interest expense | $2.67 | $2.53 | $1.36 | $2.92 |
| Net income | ||||
| Net income | $0.87 | $8.06 | $8.11 | $13.54 |
| Income (for common shares) | ||||
| (in millions $) | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 | 30 Jan 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $487.27 | $668.21 | $700.85 | $647.82 |
| Cost of revenue | ||||
| Gross Profit | $112.5 | $172.63 | $203.88 | $182.86 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $190.07 | $76.53 | $86.22 | $73.85 |
| Operating income | -$76.81 | $96.68 | $118.62 | $109.97 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $5.9 | -$12.29 | $25.45 | $18.25 |
| Interest expense | $14.37 | $14.69 | $13.33 | $10.73 |
| Net income | ||||
| Net income | -$97.64 | $101.98 | $79.53 | $83.13 |
| Income (for common shares) | ||||
| (in millions $) | 29 Oct 2021 | 29 Jul 2021 | 30 Apr 2021 | 30 Jan 2021 |
|---|---|---|---|---|
| Net income | $17.43 | $16.42 | $8.21 | -$97.07 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $29.43 | $17.47 | $7.99 | $57.87 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$6.53 | -$3.38 | -$1.07 | $7.85 |
| Financing activities | ||||
| Dividends paid | -$1.37 | -$0.91 | -$0.45 | -$12.45 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$17.65 | $5.72 | $7.08 | -$63.01 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $5.24 | $19.81 | $14 | $2.71 |
| (in millions $) | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 | 30 Jan 2018 |
|---|---|---|---|---|
| Net income | -$97.07 | $94.28 | $79.85 | $83.1 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $57.87 | $89.53 | $111.83 | $124.27 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $7.85 | -$5.68 | -$70.64 | -$20.56 |
| Financing activities | ||||
| Dividends paid | -$12.45 | -$97.57 | -$97.25 | -$97.17 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$63.01 | -$85.87 | -$42.47 | -$104.08 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $2.71 | -$2.02 | -$1.28 | -$0.36 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 46.29M |
| Revenue | $458.86M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $30.58M |
| Revenue Q/Q | 11.96% |
| Revenue Y/Y | -13.47% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.41 |
| EPS | $0.66 |
|---|---|
| ROA | 5.23% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.01 |
| Quick ratio | 1.54 |